AI assistant
PALISADE BIO, INC. — Director's Dealing 2013
Jan 30, 2013
35274_dirs_2013-01-30_293d9c67-be48-4d60-90cb-8cf969d4f3fc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2012-12-31
Reporting Person: GARR RICHARD (Director, CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-04-11 | Common Stock Purchase Option | $1.09 | A | 640855 | Acquired | 2022-04-11 | Common Stock (640855) | Direct |
| 2012-04-11 | Common Stock Purchase Option | $1.09 | A | 412552 | Acquired | 2022-04-11 | Common Stock (412552) | Direct |
Footnotes
F1: Right to Buy
F2: Represents Reporting Person's long-term incentive grant for 2012, which was granted on April 11, 2012. The option was granted pursuant to the company's 2010 Equity Compensation Plan.
F3: For so long as Reporting Person continues to be a service provider, the Option vests quarterly over a three year period commencing on the April 11, 2012, the Grant Date.
F4: Represents Reporting Person's short term incentive bonus for 2011, which was granted on April 11, 2012. The option was granted pursuant to the company's 2010 Equity Compensation Plan.